Effectiveness of the treatment of generalized tuberculosis in HIV-infected patients


Abstract. The treatment of tuberculosis in HIV-infected persons is a complex task and often requires intensive therapy with intravenous administration of antituberculosis drugs, especially in generalized forms, malabsorption, presence of enteropathy, hepatitis B and C, severe condition. One of the dangerous forms of tuberculosis in HIV-infected people is meningeal tuberculosis. In these cases, the effectiveness of treatment for HIV-positive patients depends on timely detection, diagnosis of resistance to antituberculosis drugs, presence of other opportunistic diseases. Here is an example of treating a HIV-positive patient with miliary tuberculosis with lung damage, lymph nodes and meningeal tuberculosis caused by a multiresistant strain of tuberculosis. The treatment was performed taking into account drugs that cross the blood-brain barrier, drug sensitivity test, immunosuppression and the presence of malabsorption. Timely intensive therapy with intravenous administration of medications for medical sensitivity allowed to obtain positive dynamics and cure the patient in the short term.

Keywords: HIV infection, generalized tuberculosis, tuberculous meningoencephalitis, infusion therapy.


Feshchenko YI, Gumeniuk MI, Korolyuk O. Ya. Existing opportunities to increase the effectiveness of tuberculosis treatment. Infusion chemotherapy. 2018. 1 (18): 6-12. Doi: 10.32902/2663-0338-2018-1-6-12.

Центр громадського здоров’я Міністерства охорони здоров’я України. Туберкульоз – 2018. Режим доступу: https//phc.org.ua/pages/diseases/tuberculosis/surveillance.

Wang JY, Hsueh PR, Wang SK et al. Disseminated Tuberculosis. A 10-Year Exspience in a Medical Center. Medicine (Baltimore). 2007; Vol. 86: 39-46.

Ribeiro S, Trabulo D, Cardoso S, Oliveiro A, Cremers I. Disseminated Tuberculosisin an Immunocompetent Patient: The answer is in the Liver. GE Port J Gastroenterol. 2015. Vol. 23 (4): 208-213.

Sharma SK, Mohan A, Sharma A, Mitra DK. Miliary tuberculosis: new insights into an old disease. Lancet infect. Dis. 2005. Vol. 5: 415-430.

Shaw JE, Pasipanodya JG, Gumbo T. Meningeal tuberculosis: high long-term mortality despite standart therapy. Medicine (Baltimore). 2010. Vol. 89 (3): 189-195.

Rustami R, Ganiem AR, Dian S, et al. Intensified regimencontaining rifampicin and moxifloxacin for tuberculosis meningitis: an open-label, randomisedcontrolled phase 2 trial. Lancet infect. Dis. 2013. Vol. 13 (1): 27-35.

Pinhiero VG, Ramos LM, Monteiro HS et al. Intestinal permeability and malabsorbtion of rifampicin and isoniazid in active pulmonary tuberculosis. Braz J Infect Dis. 2006. Vol. 10 (6): 374-379.

Sahai I, Gallicano K, Swick L et al. Reduced plasma concentration of antituberculosis drugs in patiens with HIV infection. Ann intern Med. 1997. Vol. 127: 289-293.

Peloguin CA. Theapeutic drug monitoring in the treatment of tuberculosis. Drugs. 2002. Vol. 62: 2169-2183.

Mishin VY. Effectiveness of treatment of patients with destructive pulmonary tuberculosis with parenteral and oral administration of anti-TB drugs. Pulmonology. 2011. Vol. 1: 55-59.

How to Cite
Nikolaeva, O. D. (2019). Effectiveness of the treatment of generalized tuberculosis in HIV-infected patients. Infusion & Chemotherapy, (4), 31-35. https://doi.org/10.32902/2663-0338-2019-4-31-35

Author Biography

O. D. Nikolaeva, Shupyk National Medical Academy of Postgraduate Education, Kyiv, Ukraine

Nikolaeva Olha Dmytrivna
Associate Professore of the Department of Phthisiology and Pulmonology
10 M. Amosova str, Kyiv, 03038, Ukraine.
E-mail: demenikos@ gmail.com